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Abbreviations
AID

Activation-induced cytidinedeaminase

BCR

B cell antigen receptor

Btk

Bruton’s tyrosine kinase

CSR

Class switch-recombination

FO

Follicular

LPS

Lipopolysaccharide

MZ

Marginal zone

NP

4-Hydroxy-3-Nitrophenyl-Acetyl

PerC

Peritoneal cavity

PS

Polysaccharide

Rag1

Recombination-activating gene 1

SHM

Somatic hypermutation

TD

T cell-dependent

TI

T cell-independent

TI-1

T cell-independent type 1

TI-2

T cell-independent type 2

TLR

Toll-like receptor

Xid

X-linked immunodeficiency

XLA

X-linked agammaglobulinemia
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Abstract
Pathogenesis of infectious disease is not only determined by the virulence of the microbe but also
by the immune status of the host. Vaccination is the most effective means to control infectious
diseases. A hallmark of the adaptive immune system is the generation of B cell memory, which
provides a long-lasting protective antibody response that is central to the concept of vaccination.
Recent studies revealed a distinct function for B1b lymphocytes, a minor subset of mature B cells
that closely resembles that of memory B cells in a number of aspects. In contrast to the
development of conventional B cell memory, which requires the formation of germinal centers
and T cells, the development of B1b cell-mediated long-lasting antibody responses occurs
independent of T cell-help. T cell-independent (TI) antigens are important virulence factors
expressed by a number of bacterial pathogens including those associated with biological threats.
TI antigens cannot be processed and presented to T cells and therefore are known to possess
restricted T cell-dependent (TD) immunogenicity. Nevertheless, specific recognition of TI
antigens by B1b cells and the highly protective antibody responses mounted by them clearly
indicate a crucial role for this subset of B cells in the host’s ability to overcome the restricted TD
antibody response. Understanding the mechanisms of long-term immunity conferred by B1b cells
may lead to improving the vaccine efficacy for a variety of TI antigens.
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1
Introduction

Infectious diseases are the leading cause of mortality and morbidity worldwide. The acquisition
of virulence-encoding genetic elements by horizontal transfer, the high mutation rates of
pathogens, and the emergence of antibiotic resistance make it difficult to control infectious
diseases by therapeutic means. Vaccination is the most effective way to control infectious
diseases as it induces long-lasting immunity. A hallmark of the adaptive immune system is the
development of B cell memory, which provides a protective antibody response upon re-exposure
to the same antigen and is central to the concept of vaccination (MacLennan et al., 2000). T cells
are crucial for the formation of germinal centers, a specialized microenvironment of the
secondary lymphoid organs in which proliferation of antigen-specific B cells, affinity maturation
of B cell antigen receptor (BCR) by somatic hypermutation (SHM), and alteration of antibody
isotype by class-switch recombination (CSR) occur. The ultimate accomplishment of the
germinal center reaction is the development of memory B cells and long-lived plasma cells that
generate high affinity antibodies of different Ig isotypes (McHeyzer-Williams et al., 2001;
McHeyzer-Williams, 2003). T cell-independent (TI) antibody responses are highly protective
and develop much faster than T cell-dependent (TD) antibody responses (Maizels and Bothwell,
1985; Vos et al., 2000; Martin and Kearney, 2001). In spite of the potential utility of TI
responses as a preventive and therapeutic intervention against a wide range of pathogens, little
work has been done in this area. One reason is that, until recently, TI antibody responses have
been considered exclusively short-lived and incapable of conferring long-lasting protection.

2
T cell-dependent and -independent antigens

Protein antigens such as tetanus, diphtheria and pertussis toxins are potent immunogens. They induce
generation of antigen-specific T cells that help B cells by providing cognate and non-cognate
interactions crucial for B cell responses. Such antigens are referred to as TD antigens. Vaccines
comprised of this group of antigens generate highly protective and long-lasting antibody responses
(Zinkernagel, 2000). Antigens that induce antibody responses without T cell-help are referred to as TI
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antigens (Fagarasan and Honjo, 2000; Vos et al., 2000). TI antigens are typically resistant to proteolysis
and cannot be processed and presented to T helper cells via MHC class II, and thus are not capable of
establishing cognate interaction with T cells, which can account for the restricted immunogenic nature
of TI antigens (Lesinski and Westerink, 2001). TI type 1 (TI-1) antigens, the prototype of which is
bacterial lipopolysaccharide (LPS), activate B cells primarily by stimulating mitogenic receptors e.g.
Toll-like receptors (TLRs). Therefore, the antibodies generated by such stimuli are predominantly
polyclonal (Vos et al., 2000). On the other hand, type 2 (TI-2) antigens such as bacterial capsular
polysaccharides (PS) and other macromolecules with repetitive antigenic determinants, can induce
antibody responses by primarily cross-linking the BCR of specific B cells (Vos et al., 2000).

3
B cell subsets

Mature B cells that generate antibody responses can be divided into four subsets; namely, follicular
(FO), marginal zone (MZ), B1a and B1b subsets (Martin and Kearney, 2001; Montecino-Rodriguez and
Dorshkind, 2006). Each appears to have a distinct function in the immune system. FO B cells (also
known as B2 cells), comprise the majority of B cells in the body, re-circulate among the B-cell rich
lymphoid follicles, participate in germinal center reactions, and mount TD antibody responses
(McHeyzer-Williams, 2003). MZ B cells localized to the marginal sinus of the spleen, are strategically
located to capture blood-borne TI particulate antigens and mount a very rapid response (Martin and
Kearney, 2000; Martin and Kearney, 2001). The B1a subset is abundant in coelomic cavities but can
also be found in the spleen (Martin and Kearney, 2000; Martin and Kearney, 2001). B1a cells though
developmentally distinct from MZ B cells are also efficient in generating TI antibody responses
(Berland and Wortis, 2002). B1a and MZ B cell subsets recognize evolutionarily conserved antigens
such as phosphorylcholine moieties present on bacteria. When mice are challenged with
phosphorylcholine-expressing bacteria such as Streptococcus pneumoniae, these two B cell subsets unite
in the development of a rapid response (Martin et al., 2001). Aspects contribute to this response include,
the ability of these B cell subsets differentiate into plasmablasts rapidly. Primed accessory cells of the
myeloid lineage such as dendritic cells and macrophages appear to facilitate this response (Balasz et al.,
2002; Martin and Kearney, 2001). Nevertheless, B1a cells constitutively secrete antibodies mainly of the
IgM isotype and are referred to as natural antibodies because they occur spontaneously in human cord
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blood, in naïve “antigen-free” mice, and in normal individuals in the absence of apparent antigenstimulation (Boes, 2000). These antibodies have been shown to play an important role in controlling a
wide range of pathogens (Boes, 2000). Although the B1b subset was described years ago (Stall et al.,
1992), a functional role for these cells in protective immune responses has not been found until recently
(Alugupalli et al., 2004; Haas et al., 2005; Hsu et al., 2006).

4
B1b cells

B1b cells share a number of features with B1a cells including the expression of cell-surface
markers and anatomical location, e.g. the peritoneal cavity (PerC) (Stall et al., 1992). Both
subsets express high levels of membrane IgM and Mac1 (integrin αMac), low levels of IgD and
B220 and lack CD23 expression. The only phenotypic marker to date that distinguishes these
two B1 subsets is the expression of CD5 on B1a but not on B1b cells. Additional differences in
developmental pathways (Montecino-Rodriguez et al., 2006; Tung et al., 2006) and cytokine
responses also exist between these two subsets . Unlike the consistent expression of CD5 on B1a
cells found elsewhere, e.g. spleen, the expression of Mac1 is restricted to the B1a and B1b cells
localized to the PerC. Thus, identification of the B1b subset in sites other than PerC is limited by
the lack of any other B1b-specific phenotypic marker. Interestingly, a recent analysis of PerC
cells from chimeric mice revealed that an IgMhigh, IgDlow/-, Mac1+ B1 cell population emerges
over time in Rag1-/- mice reconstituted with wildtype peripheral lymph node cells (Hsu et al.,
2006). The majority of their PerC B1 cell population lacked CD5 expression, indicating that
lymph node cells predominantly reconstitute the B1b but not the B1a compartment. Thus, the
number of B1b cells and/or B1b cell precursors in mice could be far more abundant than those
found in coelomic cavities. The small number of B cells transferred compared to the numbers of
B1b cells recovered in the PerC of the Rag1-/- chimeras likely reflects proliferation of these cells
after transfer, as the B1 cell subsets are known to maintain their numbers in the PerC by their
unusual self-renewing capability even after an arrest of bone marrow B lymphopoiesis (Carvalho
et al., 2001; Kantor et al., 1995). Although the reasons are not clear, the mechanism for the
preferential homing of B1a and B1b cell subsets to the PerC appears to be due to their selective
attraction to CXCL13, a chemokine produced by cells in the omentum and by peritoneal
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macrophages (Ansel et al., 2002). Mice deficient in CCR7 and CXCR5, the receptor for
CXCL13, also exhibit a PerC homing defect of B1 cells (Hopken et al., 2004; Muller et al.,
2003). As a consequence of this migration impairment the immunity of the coelomic cavity is
significantly compromised in these mice (Ansel et al., 2002). Parabiosis experiments revealed
that B1 cell subsets do not actively circulate compared to B2 cells (Ansel et al., 2002).
Nevertheless, PerC B1 cells have the capability to leave the PerC upon appropriate stimulation.
In a transgenic B1 cell mouse model it was shown that microbial products induce the migration
of PerC B1 cells to mesenteric lymph nodes where they rapidly differentiate into antibodysecreting cells (Watanabe et al., 2000). Recently, it was demonstrated that Toll-like receptor
(TLR)-mediated stimulation induces a rapid and transient down-regulation of integrins resulting
in an efficient movement of cells of PerC B1 cells in a chemokine-dependent fashion (Ha et al.,
2006). These data and the presence of B1b cells or their precursors in the lymph node suggest
that they can move in a dynamic fashion and are poised to encounter pathogens not only in the
PerC but elsewhere with high frequency and thus play an important role in protective immunity.

5
Role of B1b cells in T cell-independent responses

5.1
Immunity to Borrelia hermsii

While investigating the immune mechanism required for controlling the relapsing fever
bacterium B. hermsii, we found for the first time a specific function for B1b cells in protective
immunity. Rodents are natural reservoirs for relapsing fever bacteria, and murine infection
recapitulates the critical pathophysiological aspects of the human disease ( Southern and
Sanford, 1969; Cadavid et al., 1994; Garcia-Monco et al., 1997; Gebbia et al., 1999; Alugupalli
et al., 2001a; Alugupalli et al., 2001b; Alugupalli et al., 2003b). The hallmark of this infection is
recurrent episodes of high-level bacteremia (~108 bacteria/ml blood), each caused by
antigenically distinct populations of bacteria generated by DNA rearrangements of the genes
encoding the variable major proteins (Barbour, 1990). Remarkably, each episode is resolved
rapidly within one to three days (Barbour and Bundoc, 2001; Connolly and Benach, 2001;
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Alugupalli et al., 2003a). TI B cell responses are necessary and sufficient for controlling B.
hermsii infection (Barbour and Bundoc, 2001; Alugupalli et al., 2003a). IgM is the most
dominant isotype in TI responses (Martin and Kearney, 2001). We found that mice deficient only
in the secretion of IgM, but not SHM or CSR, suffer persistently high bacteremia and become
moribund, indicating that IgM is the essential antibody isotype required for controlling B.
hermsii (Alugupalli et al., 2003a). Consistent with these results, it was shown that passive
transfer of IgM from convalescent mice is sufficient to confer protection (Arimitsu and Akama,
1973; Yokota et al., 1997). Nevertheless, it was demonstrated that other IgG isotypes, e.g. IgG3
and IgG2b are also capable of conferring passive protection (Yokota et al., 1997). Since the
control of a bacteremic episode occurs rapidly e.g. with in one to three days and IgM, the first
isotype to be made during primary immune response to antigen/pathogen exposure (Boes, 2000),
we anticipated that neither the generation of other immunoglobulin isotypes by CSR nor affinity
maturation of variable regions of the immunoglobulin by SHM which typically takes more than a
week, play a critical role in this process. Activation-induced cytidine deaminase (AID) is
essential for both CSR and SHM that typically occurs during a TD germinal center reaction
(Muramatsu et al., 2000). Indeed, the resolution of the bacteremia and the kinetics of the B.
hermsii-specific IgM response are indistinguishable between wildtype and AID-/- mice,
demonstrating that unmutated IgM is sufficient for controlling B. hermsii infection (Alugupalli et
al., 2004).

To identify the B cell subsets that are capable of generating this protective IgM response
we have infected IL-7-/- mice, which are deficient in FO B cells but not B1a, B1b and MZ B cell
subsets (Carvalho et al., 2001) and found that they control bacteremia as efficiently as wildtype
mice (Alugupalli et al., 2003a). Using bone marrow chimeric mice deficient in B1a cells, we
have ruled out a requirement for B1a cells in the protective response against B. hermsii
(Alugupalli et al., 2004). Severe bacterial burden in splenectomized mice during the primary
bacteremic episode suggested that MZ B cells play a role in controlling B. hermsii (Alugupalli et
al., 2003a; Alugupalli et al., 2003b). Consistent with this, recently Bockenstedt and colleagues
have demonstrated that MZ B cells mount anti-B. hermsii antibody responses (Belperron et al.,
2005). Nonetheless, the rapid control of bacteremia during secondary episodes of a virulent
strain or a moderate bacteremic episode by a partially attenuated strain of B. hermsii in
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splenectomized mice suggested that MZ B cells are not the only subset that contributes to
protection. Having ruled out a role for the other three B cell subsets, we investigated whether
B1b cells might play a role in controlling B. hermsii bacteremia. Mutations affecting the BCR
signaling pathway result in a severe deficiency of B1 cell subsets, which are the major producers
of IgM (Berland and Wortis, 2002). Due to the lack of a B1b-deficient mouse model, we
examined a potential role for B1b cells in X-linked immunodeficient (xid ) mice (Khan et al.,
1995; Thomas et al., 1993). Bacteremic episodes in xid mice are more severe than those of
wildtype mice, which suggest that B1b cells may play a role in controlling B. hermsii (Alugupalli
et al., 2003a). Although xid mice were clearly impaired in bacterial clearance, by four weeks
post-infection bacteremia was completely resolved, an apparent paradox if B1b cells are indeed
critical for controlling bacteremia. One possible explanation is that the markedly reduced B1b
subset of xid mice expands during this infection. In fact Kearney and colleagues (Martin et al.,
2001) have previously shown that antigen-specific TI B cell clones expand in mice immunized
with S. pneumoniae. To detect a potential expansion of B1b cells we analyzed the frequencies of
PerC B cells in xid mice. Remarkably, the frequency of B1b cells as defined by the surface
markers IgMhigh, IgDlow, Mac1+ and CD5- in convalescent xid mice is significantly greater than in
uninfected xid mice (Fig. 1A) and comparable to the frequency of B1 cells in wildtype mice
(Alugupalli et al., 2003a). This expansion was selective for B1b cells but not for B1a or B2 cell
subsets (Fig. 1B) and occurred regardless of whether the xid mice were infected with a highly
virulent or a partially attenuated strain of B. hermsii. These findings indicate a role for B1b cells
in the control of both high and moderate bacteremic episodes (Alugupalli et al., 2003a). Since
IgM is essential for controlling this infection and B1b expansion was detected as early as by
seven days post-infection (Fig. 1B), we predicted that xid mice would be capable of mounting an
anti-B. hermsii IgM response, despite their inherent deficiency in pre-immune IgM levels. As
predicted, with some delay, xid mice generated a specific IgM response coincident with the
resolution of bacteremia (Alugupalli et al., 2007).
A significant increase in B1b cell numbers also occurs in TCR-βxδ-/- mice, demonstrating
that this expansion is a TI process (Fig. 1C). Remarkably, the convalescent TCR-βxδ-/- were as
resistant as that of the wildtype mice to re-infection suggesting that a memory-like response can
be generated by B1b cells independent of a germinal center reaction (Alugupalli et al., 2004).
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Indeed, we eliminated a role for two very important TD germinal center events namely SHM and
CSR in controlling B. hermsii infection (Alugupalli et al., 2004). Movement of PerC B1 cells is
crucial for their protective immune responses (Ansel et al., 2002; Ha et al., 2006; Hopken et al.,
2004; Muller et al., 2003). We, therefore, anticipated that B1b cells leave the PerC to
differentiate into IgM secreting plasma cells that are critical for the B. hermsii immunity. Upon
infection with B. hermsii, a rapid egress of B1b cells from the wildtype mouse PerC was also
observed. The magnitude of the egression was directly proportional to the bacterial burden (Fig.
1D). Interestingly, soon after resolution of bacteremia B1b cell numbers in the PerC were rapidly
restored to basal levels, suggesting an active turnover and that these cells are capable of
participating in protective immunity in the blood stream (Fig. 1D).

To directly determine whether B1b cells are capable of providing long-lasting immunity,
we transferred B1b cells from convalescent mice into Rag1-/- mice that are otherwise completely
incapable of eliminating B. hermsii (Alugupalli et al., 2003a). Rag1-/- mice reconstituted with
B1b cells controlled B. hermsii bacteremia, demonstrating for the first time a crucial role for B1b
cells in protective immunity (Alugupalli et al., 2004). The fact that naïve mice suffer recurrent
bacteremic episodes indicates that naïve B1b cells are functionally less effective than
convalescent B1b cells. As expected, transfer of the same number of naïve B1b cells to Rag1-/mice conferred only partial protection (Alugupalli et al., 2004). Consistent with the requirement
for IgM in the clearance of bacteremia, the transferred B1b cells in Rag1-/- mice confer
protection by mounting a specific IgM response against B. hermsii, and the generation of this
IgM is coincident with the resolution of bacteremia. B1b cells do not mount an antibody
response in the absence of specific stimulation, indicating that they maintain a quiescent state
like conventional memory B cells (Alugupalli et al., 2004). This property of B1b cells is not
unique to the B. hermsii infection, and recently has been extended to another important human
pathogen, S. pneumoniae.

5.2
Immunity to Streptococcus pneumoniae
A number of clinically important pathogens including S. pneumoniae, Haemophilus influenzae
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and Neisseria meningitidis express PS capsules (Lesinski and Westerink, 2001). Some pathogens
associated with biological threats such as Bacillus anthracis, the etiological agent of anthrax,
express capsules made of poly-γ-D-glutamic acid (Wang and Lucas, 2004). Due to the restricted
immunogenicity for TD responses, the masking of potentially immunogenic TD protein antigens,
and the provision of serum resistance, capsules enable the persistence of these pathogens in the
host and eventually cause serious diseases ranging from bacteremia to meningitis (Kelly et al.,
2004; Scorpio et al., 2007). A critical factor in preventing these infections from becoming
systemic is the ability of B cells to rapidly generate protective antibodies against capsules. As
mentioned earlier, bacterial capsules are TI-2 antigens and antibodies to capsules are highly
protective. In fact, the introduction of conjugate vaccine against the capsular PS (Hib) had a
major impact in reducing the incidence of H. influenzae type b disease worldwide (Kelly et al.,
2004).
Using a well-established murine model of S. pneumoniae infection in mice sufficient or
deficient in CD19, Haas and colleagues found that CD19, though an important molecule for B
cell development is, surprisingly, not necessary for generating protective IgM or IgG3 responses
against the capsular PS of S. pneumoniae (Haas et al., 2005). CD19-/- mice have a severe
deficiency in B1a cells and MZ B cells but not B1b cells suggesting that this subset is
responsible for the observed anti-PS specific antibody response. Conversely, CD19 transgenic
(CD19Tg) mice that are severely deficient in B1b cells but not B1a or MZ B cells were incapable
of mounting an antibody response to capsular PS (Haas et al., 2005). Immunization of CD19-/but not CD19Tg mice with capsular PS protects mice from a lethal S. pneumoniae challenge.
These correlations suggest that B1b cells might be involved in generating long-lasting anti-PS
responses. To identify the B cell subsets responsible for the anti-PS antibodies, Haas and
-/-

colleagues transferred wildtype B1b, B1a or MZ B cells into Rag1 mice. None of the
reconstituted mice spontaneously generated anti-PS antibodies over a period of four weeks.
However, upon PS immunization only B1b-reconstituted mice mounted an exuberant anti-PS
IgM and IgG3 response (Haas et al., 2005). Unreconstituted mice died as early as two days postinfection when challenged with as few as 100 colony-forming units of S. pnuemoniae. In striking
-/-

contrast greater than 75% of Rag1 mice reconstituted with B1b cells survived this lethal dose
(Haas et al., 2005). These data demonstrate yet another example of B1b cell-mediated immunity
to a clinically important bacterial pathogen. In the pneumococcal infection mouse model B1a cell
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subsets were also shown to play an important complementary role in protective immunity by
virtue of their natural antibody repertoire. Unlike constitutively secreted natural antibodies,
antibodies generated by B1b cells are inducible only by specific antigen stimulation (Haas et al.,
2005), as in the case of B. hermsii-specific B1b cell response (Alugupalli et al., 2004). To date,
two independent studies, using clinically distinct murine infection systems, reveal a long-lasting
and antigen-specific B1b cell response (Alugupalli et al., 2004; Haas et al., 2005). In both cases
the function of B1b cells was revealed unpresumptuously. Therefore, it is tempting to consider
an important role for B1b cells in protection against other infections.
5.3
Response to NP-Ficoll, a model TI-2 antigen
Due to the division of labor within TI B cell subset responses during an infection and the host- or
tissue-tropism of bacterial pathogens, it is not easy to dissect the role of B1b cells in other
infection systems. Moreover, the lack of a B1b cell-specific marker currently poses a challenge
in tracking B1b cell responses in compartments such as the spleen, lymph nodes and bone
marrow. Nevertheless, while exploring the identity of B cell populations involved in the response
to 4-hydroxy-3-nitrophenyl acetyl (NP), a frequently used hapten for studying antigen-specific
antibody responses in mice, MacLennan and colleagues revealed an involvement for B1b cells in
anti-NP responses (Hsu et al., 2006). NP-conjugated polysaccharide Ficoll is a widely used
model antigen for studying TI-2 responses. It is known that extrafollicular antibody responses
induced by immunization of NP-Ficoll persist for long periods of time (de Vinuesa et al., 2000).
Adoptive transfer experiments were performed using Rag1-/- mice reconstituted with wildtype
mouse PerC cells which were depleted of either B2 or B1a cells. These mice generated normal
levels of NP-specific IgM and IgG3 antibodies (Hsu et al., 2006). In contrast, Rag1-/- mice
reconstituted with B1a and B1b cell-depleted PerC cells failed to generate NP-specific antibody
responses indicating B1b cells are involved in this response (Hsu et al., 2006). In support of the
specific induction of B1b cell-derived IgM seen in B. hermsii and S. pneumoniae infection
models (Alugupalli et al., 2004; Haas et al., 2005), NP-specific B1b cells did not generate an
anti-hapten response spontaneously (Hsu et al., 2006). The magnitude of the anti-NP response
increased dramatically following NP-Ficoll immunization (Hsu et al., 2006), revealing once
again a requirement for specific-antigen stimulation in the B1b cell response (Alugupalli et al.,
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2004; Haas et al., 2005; Hsu et al., 2006). Surprisingly, Rag1-/- mice reconstituted with lymph
node B cells also generated NP-specific IgM and IgG3 responses as efficiently as the PerC cellreconstituted Rag1-/- mice (Hsu et al., 2006). Analysis of PerC cells isolated from lymph node
cell-reconstituted Rag1-/- mice revealed a robust generation of B1b cells but not B1a cells.
Approximately 2% of lymph node B220+ cells are IgMhigh and IgDlow that are characteristics of
B1b cells. These results indicate that B1b cells and/or B1b cell precursors are present in
lymphoid compartments and are poised to contribute to TI-2 antigen-specific responses.
Recently, it was demonstrated that IgM memory B cells are generated upon NP-Ficoll
immunization and such cells can be detected in spleen (Obukhanych and Nussenzweig, 2006).
The phenotype of these B cells is distinct from that of MZ B and FO B cells. It is possible that
these cells might represent splenic B1b cells (Obukhanych and Nussenzweig, 2006).
6
Activation of antigen-specific T cell-independent B cell responses
Antigens driving B1b cell responses appear to be heterogenous. For example, one B. hermsii
antigen targeted by B1b cells is a protein implicated in virulence of this pathogen (M. J.
Colombo and K. R. Alugupalli, unpublished data). In the case of S. pneumoniae it is a
carbohydrate (Haas et al., 2005), whose expression is implicated in a variety of immune evasion
strategies. Thus, the recognition of biochemically different bacterial products and even synthetic
haptens such as NP (Hsu et al., 2006) by B1b cells clearly indicates that the B1b repertoire is
capable of responding to a wide spectrum of antigens. Unbiased analysis of the CDR3 regions of
VH genes revealed that unlike B1a cells, B1b cells have high junctional diversity that is
comparable to B2 cells (Kantor et al., 1997; Tornberg and Holmberg, 1995). Furthermore,
immunization with NP-Ficoll can result in low levels of SHM in the VH regions even without T
cell help (Toellner et al., 2002). This process presumably occurs by BCR cross-linking induced
AID expression without the requirement for CD40-CD40L (Faili et al., 2002; Weller et al.,
2001). This could also explain the existence of other antibody isotypes e.g. IgG3 by CSR during
TI responses (Martin and Kearney, 2001). However, unlike conventional B2 cells, the affinity
and overall Ig repertoire of B1b cell-derived antibodies may be limited due to the lack of an
involvement with TD germinal center reactions.
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6.1
Role of Btk in T cell-independent B cell responses

Although antigen-specific B1b cells respond to various TI antigens e.g. pneumococcal PS,
hapten NP and B. hermsii surface protein (Haas et al., 2005; Hsu et al., 2006) (M. J. Colombo
and K. R. Alugupalli, unpublished data), the mechanism of activation of this response can vary.
Xid mice, which carry a point mutation in Bruton’s tyrosine kinase (Btk), a cytoplasmic kinase
belonging to the Tec family of kinases is crucial for BCR-mediated activation. B cells of these
mice cannot respond to anti-BCR cross-linking and are therefore impaired primarily in response
to TI-2 antigens such as NP-Ficoll (Amsbaugh et al., 1972; Khan et al., 1995; Scher et al., 1975;
Thomas et al., 1993). In fact, these mice cannot generate protective antibody responses to
capsules of S. pneumoniae or B. anthracis (Briles et al., 1981; Wang and Lucas, 2004). Mice that
have a targeted deletion in the Btk gene recapitulate the xid mouse phenotype (Khan et al., 1995).
Surprisingly, the phenotypes seen in these mice are not identical to X-linked
agammaglobulinemia (XLA) patients, the human equivalent of xid. Mice deficient in Tec, a
kinase belonging to the same family as Btk, have no major phenotypic alterations of the immune
system (Ellmeier et al., 2000). Interestingly, mice deficient in both Btk and Tec exhibit a
phenotype that is similar to human XLA (Ellmeier et al., 2000). Although the exact reasons for
these differences is not clear, it was demonstrated that retroviral-mediated transfer of the human
Btk gene corrects a number of functions including TI-2 responses in Btk and Tec double
knockout mice, indicating a functionally conserved and crucial role of Btk in both mice and
humans (Yu et al., 2004). Xid mice respond to LPS, a model TI-1 antigen (Hiernaux et al., 1983;
Mosier et al., 1977). The moderate impairment of xid mouse B cells to LPS stimulation (Khan et
al., 1995) is likely due to a potential role for Btk in TLR-mediated signaling rather than its role in
BCR-mediated signal (Jefferies et al., 2003; Jefferies and O'Neill, 2004), as the IgM response
induced by LPS is polyclonal and non-specific (Andersson et al., 1972; Mosier et al., 1976). In
support of this, it was shown that mice deficient in MyD88 involved in TLR- but not BCRmediated signaling exhibit impaired LPS-induced B cell activation (Kawai et al., 1999).In fact,
these mutant mice generate normal anti-NP-Ficoll antibody responses (Schnare et al., 2001).
These data together reveals the critical role for Btk in TI-2 responses.
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Although xid mice are deficient in B1 cells, as previously mentioned (see Sect. 5.1), the
impairment of a specific antibody response to TI-2 antigens is not entirely due to a deficiency of
these B cell subsets. Increasing the B cell numbers in xid mice by blocking apoptosis of B cells
with the transgenic expression of Bcl2, does not restore B cell functions including TI-2 responses
in xid mice (Woodland et al., 1996). Transgenic expression of IL-9 or injection of this cytokine
induces selective expansion of B1b cells in wildtype mice (Vink et al., 1999). Such a transgene
can even correct the B1b cell deficit of xid mice but does not restore the specific antibody
response to pneumococcal capsular PS or NP-Ficoll (Knoops et al., 2004). In contrast, a Btk
transgene restores NP-Ficoll and antiviral TI-2 responses of xid mice in a dose-dependent
fashion (Pinschewer et al., 1999; Satterthwaite et al., 1997). Furthermore, the defective anti-PS
response of xid mice is not attributed to lack of a specific VH gene family involved in TI-2
responses (Feng and Stein, 1991; Selinka and Bosing-Schneider, 1988). These data suggest that
the impaired TI response in xid mice is due to a compromised BCR-mediated signal rather than a
deficiency in B1b cells or the potential deficiency in the BCR repertoire itself.

6.2
Role of co-stimulatory signals in T cell-independent B cell responses

6.2.1
CD40 and its ligand CD40L
Despite a BCR-mediated signaling defect, xid or Btk-/- mice generate near normal responses to
TD antigens (Khan et al., 1995). This response is likely mediated by CD40-Cd40L costimulation provided by T cells, since mice deficient in both Btk and CD40 are severely
compromised for TD antibody responses (Khan et al., 1997). In fact, in vitro co-stimulation of
xid B cells with CD40 compensates the need for Btk in BCR-mediated signal as detected by cell
cycle progression and nuclear translocation of NF-κB, a transcription factor involved in a variety
of B cell responses (Mizuno and Rothstein, 2003; Mizuno and Rothstein, 2005). Consistent with
this, injection of anti-CD40 antibodies as a surrogate for CD40L restores immune responses to
NP-Ficoll in xid mice (Dullforce et al., 1998; Vinuesa et al., 2001). In striking contrast to that of
typical TI-2 responses induced by capsular PS or NP-Ficoll, the antibody response to B. hermsii
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is clearly different. For example, unlike pure TI-2 antigens, an active infection is expected to
engage several immune activation pathways. Although xid mice suffer more severe bacteremia
than wildtype mice, they control all episodes of B. hermsii bacteremia and the resolution of the
infection coincides with an expansion of B1b cells in these mice (see Sect. 5.1) (Alugupalli et al.,
2003a). Xid mouse B cells are defective in homeostatic proliferation (Cabatingan et al., 2002;
Woodland and Schmidt, 2005), hence this B1b cell expansion is likely to be antigen-driven. In
support of this, xid or Btk-/- mice generate an antigen-specific IgM response capable of
controlling infection (Alugupalli et al., 2007). The magnitude of the specific IgM response in
wildtype mice is comparable to that of TCR-βxδ-/- mice, implying an unlikely for role CD40CD40L-mediated co-stimulation, provided by T cells in this infection (Alugupalli et al., 2007)
(Fig. 2A). The observation that CD40L-/- mice generate a robust TI IgM response to the related
bacterium B. burgdorferi supports this notion (Fikrig et al., 1996). Although the physiological
relevance of CD40-CD40L interaction in TI responses is not clear, the above data indicate that a
role exists for alternate pathways of activation during TI responses.

6.2.2
Complement component C3 and its receptor CR1/2

The high expression of CR1/2, the C3 receptor on MZ B cells (Zandvoort and Timens, 2002), is
necessary for specific targeting of C3 conjugated TI-2 antigens such as Pneumococcal capsular
PS to MZ B cell (Breukels et al., 2005; Guinamard et al., 2000). Mice deficient in C3 have
reduced responses to TI-2 antigens (Guinamard et al., 2000). Some viral pathogens also behave
like TI antigens and induce TI-2 like responses in vivo (Fehr et al., 1998; Ochsenbein et al.,
1999; Szomolanyi-Tsuda et al., 2001; Szomolanyi-Tsuda and Welsh, 1998). Studies of vesicular
stomatitis virus have demonstrated a correlation between antigen repetitiveness (TI-2 like
arrangement) and the degree to which B-cell activation is independent of T cells. The rigidly
structured Poliovirus efficiently induces neutralizing IgM antibodies independent of T cell-help
(Fehr et al., 1998). For example, Poliovirus and Vaccinia virus expressing vesicular stomatitis
virus glycoproteins do not induce antibody responses in xid mice (Pinschewer et al., 1999;
Szomolanyi-Tsuda et al., 2001). However, as mentioned earlier, a Btk transgene compliments
these responses in xid mice suggesting that BCR-signaling is the limiting component
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(Pinschewer et al., 1999). However, impaired TI responses to these viral pathogens, in C3-/- or
CR2-/- mice, implied that simultaneous engagement of C3-coupled antigen to CR1/2 and BCR
promotes B cell stimulation (Ochsenbein et al., 1999; Szomolanyi-Tsuda et al., 2006). In fact,
priming of human B cells with C3 engagement to CR1/2 enhances anti-IgM-mediated B cell
activation even to very low levels of BCR crosslinking (Carter and Fearon, 1989; Carter et al.,
1988). This co-stimulatory pathway seems to be more appropriate for the activation of MZ B
cells than B1b cells. For instance, the B1b but not MZ B cells are crucial for the clearance of B.
hermsii and C3-/- mice control this infection efficiently (Connolly and Benach, 2001; Connolly et
al., 2004). The kinetics of the anti-B. hermsii IgM response in C3-/- mice is comparable to that of
wildtype mice (Fig. 2A). This result is in agreement with the C3-independent IgM-mediated
killing of relapsing fever bacteria (Connolly and Benach, 2001; Connolly et al., 2004).

Xid B cells respond to TI-2 antigens when co-stimulated by IL-1 (Couderc et al., 1987).
However, we found that IL-1R-/- mice generate robust IgM response to B. hermsii (Fig. 2A)
(Alugupalli et al., 2007). Our results on the pathogen-specific IgM response in xid or Btk-/mouse infections suggested that even in the absence of normal BCR-mediated signaling, B.
hermsii is capable of rapidly activating antigen-specific B cells, presumably by stimulating other
signaling pathways such as the TLR-mediated pathway. In fact, when xid B cells are costimulated with TLR ligands, they respond to BCR cross-linking (Couderc et al., 1987).

6.2.3
Toll-like receptors

TLRs play important roles in activation of the immune system (Takeda and Akira, 2005).
Importantly, TLR9 has been shown to activate auto-reactive B cells (Leadbetter et al., 2002) and
memory B cells (Bernasconi et al., 2002), indicating a possible role for TLR9 in the development
of rapid and long-lasting TI-2 antibody responses. B. hermsii being a prokaryote is expected to
contain a high frequency of CpG DNA, the ligand for TLR9. Despite these expectations, TLR9-/mice generate rapid anti-B. hermsii IgM responses. B. hermsii possess other potential TLR
ligands such as lipoproteins, the ligands for TLR2 (Shang et al., 1998) that could redundantly
activate distinct members of the TLR family, thereby restoring responses in xid mice. Indeed,
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mice deficient in MyD88, a common cytoplasmic adaptor for all TLRs except TLR3, exhibited a
significantly delayed anti-B. hermsii IgM response (Fig. 2B). Analysis of individual TLR
knockout mice revealed important roles for TLR1 and TLR2 in anti-B. hermsii IgM responses
(Alugupalli et al., 2007). CD14 is known to augment TLR2-mediated responses and as expected,
CD14-/- mice have impaired antibody response to B. hermsii (Alugupalli et al., 2007). CD14 is
not only involved in TLR2 signaling but also in TLR4-mediated signaling. Although B. hermsii
is not a Gram-negative bacterium and hence does not contain LPS, other evolutionarily distant
microbial components such as glycolipids of Treponema (Schroder et al., 2000), pneumolysin of
S. pneumoniae (Malley et al., 2003) and fusion protein of respiratory syncitial virus (Kurt-Jones
et al., 2000) are recognized by TLR4. This may explain the delayed and reduced B. hermsiispecific IgM response in TLR2-/- mice. The magnitude of the specific IgM response in TLR4-/mice was also somewhat lower than wildtype mice (Alugupalli et al., 2007). As expected, this
potential TLR4-mediated response did not resemble an LPS-induced response, since mice
deficient in MD2, a protein crucial for the LPS response (Nagai et al., 2002), generated normal
antibody responses (Alugupalli et al., 2007). These results indicate that B. hermsii may also
signal through TLR4 in addition to TLR1 and TLR2, by a mechanism distinct from that of LPSinduced stimulation. Mice deficient in TLR3, which is involved in recognizing double-stranded
RNA, a signature for viral rather than bacterial infection, generated IgM responses comparable to
wildtype mice (Alugupalli et al., 2007).

Due to the redundancy in TLRs, we tested whether MyD88 provides synergistic or
partially redundant functions in triggering an antibody response to B. hermsii in xid mice.
Indeed, mice deficient in both Btk and MyD88 are severely compromised in IgM production and
bacterial clearance but not TD antibody responses that utilize CD40-CD40L (Alugupalli et al.,
2007). Despite a normal response both in terms of kinetics and magnitude of specific IgM or IgG
to the model TD antigen NP-conjugated chicken gammaglobulin, Btk x MyD88-/- mice are
unable clear B. hermsii even transiently, highlighting the critical role for TI responses in
protective immunity (Alugupalli et al., 2007) (Fig. 2B). Although B1b cells are capable of
efficiently recognizing chemically distinct antigens, these data suggest the involvement of a costimulatory mechanism in B1b cell activation during TI responses. Understanding the source of
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TLR signaling and how they regulate B1b cell function may help develop strategies to restore
efficient responses in individuals with impaired TI responses.

7
Impaired T cell-independent B cell responses

Children and the elderly respond poorly to TI antigens, and as a consequence suffer severe and
recurrent infections by both encapsulated and non-encapsulated bacteria (Kelly et al., 2004;
Kelly et al., 2005; Lesinski and Westerink, 2001). A number of possibilities could account for
this impairment, some of which are reminiscent of the defects seen in xid mice, suggesting that
the xid mouse is an appropriate model for studying impaired TI responses in children. Similar to
the BCR-mediated activation defect of xid B cells (Couderc et al., 1987), it has been shown that
the B cells of neonatal, very young and aged wildtype mice exhibit an activation defect to PS
antigens and multivalent membrane Ig crosslinking, a mimic of TI-2 antigen-induced stimuli
(Chelvarajan et al., 1998; Chelvarajan et al., 1999; Snapper et al., 1997). This impairment of the
surface IgM cross-linking and NP-Ficoll responses in neonatal B cells can be corrected by a
number of above mentioned (see Sect. 6) co-stimulatory signals for xid B cells (Couderc et al.,
1987; Vinuesa et al., 2001) such as CD40-L, TLR ligands, IL-1 and IL-6 (Chelvarajan et al.,
1998; Chelvarajan et al., 1999; Snapper et al., 1997). A defect in accessory cell-mediated costimulation for neonatal and aged mouse B cell activation has also been proposed for the poor
responses of children and the elderly. These accessory cells are mainly of the myeloid lineage,
such as monocytes and macrophages but not T cells (Bondada et al., 2000; Chelvarajan et al.,
2004; Chelvarajan et al., 2005; Chelvarajan et al., 2006; Landers et al., 2005; Yan et al., 2004a;
Yan et al., 2004b). In fact, compared to adult human monocytes, neonatal monocytes express
significantly lower levels of MyD88 protein, which is required for IL-1 and almost all TLRmediated signalings (Yan et al., 2004b). In agreement with these signaling defects, we have
recently demonstrated that mice deficient in both MyD88 and Btk are severely compromised for
TI antibody responses (see Sect. 6.2.3).

The lack of appropriate B cell subsets and/or IgM memory B cells could also explain the
impaired TI responses in the young (Kruetzmann et al., 2003; Zandvoort et al., 2001). For
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example, the lack of MZ B cell development and the low expression of CR1/2 on MZ B cells in
the spleens of children under 2 years of age has been suggested as a reason for their impaired
responses to PS (Zandvoort and Timens, 2002). Nevertheless, upon immunization with NPFicoll, pyk-2-/- mice, deficient in MZ B cells but not B1 cells, generate IgM and IgG3 antibody
responses more than two orders of magnitude higher than pre-immune levels (Guinamard et al.,
2000). This implies that other B cells, likely B1b cells, play an important role in this TI-2
response. In agreement with this possibility two independent studies reviewed here (see Sect. 5.2
& 5.3) provided direct evidence using Rag1-/- chimeras that B1b cells generate the majority of
the anti-TI-2 IgM and IgG3 responses to NP-Ficoll and PS (Haas et al., 2005; Hsu et al., 2006).
It is interesting that the splenic localization of PS conjugates can also be independent of the
presence of C3 (Breukels et al., 2005), which could explain the significant NP-Ficoll response in
pyk-2-/- mice (Guinamard et al., 2000). In agreement with this, mice deficient in CD19, the
signal-transducing moiety of the C3 receptor CR1/2, generate B1b cells normally and mount
efficient protective antibody responses to capsular PS (Haas et al., 2005). In fact, C3-/- mice also
generate normal IgM responses to B. hermsii (Fig. 2A) (Connolly and Benach, 2001; Connolly et
al., 2004). While it is not clear that all distinctions between B cell subsets defined in the mouse
hold true for humans, these data also suggest that children lack sufficient protection from
functional IgM-secreting (memory) B1b cells. Such a lack in the rapid as well as long-lasting
responses to TI antigens by B1b cells may explain recurrent infections by encapsulated bacterial
pathogens in children.

8
Memory B1b cells
The functional definition of immunological memory is the ability of the immune system
to respond more rapidly and effectively to pathogens that have been encountered previously and
reflect the pre-existence of clonally expanded populations of antigen-specific lymphocytes
(Janeway et al., 2004). The long-term immunity provided by B1b cells functionally resembles
that of canonical B cell memory, however it is generated and maintained in the complete absence
of T cells (Alugupalli et al., 2004).
The B1b cell responses to three distinct TI antigens reviewed here (Sect. 5.1, 5.2.and 5.3)
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have revealed strikingly common characteristics to memory B cell responses. Such
characteristics include i) the generation of B1b cell responses that do not require continuous B
lymphopoeisis (Alugupalli et al., 2003a; Carvalho et al., 2001); ii) B1b cells maintain their
numbers by self-renewal (Kantor et al., 1995); iii) B1b cells maintain a quiescent state in terms
of their differentiation into plasma cells, and their activation requires specific-antigenic
stimulation (Alugupalli et al., 2004; Haas et al., 2005; Hsu et al., 2006); and iv) B1b cells
generate long-lasting antibody responses (Alugupalli et al., 2004; Haas et al., 2005; Hsu et al.,
2006). In the B. hermsii-infection system, expanded B1b cells persist for a remarkably long-time
in convalescent mice (Fig. 1B) and upon challenge, expanded B1b cells rapidly differentiate into
antibody secreting cells (Alugupalli et al., 2004). While naïve B1b cells also generate specific
IgM, the magnitude of the response is significantly lower compared to that of expanded B1b
cells. The kinetics of the IgM response is also considerably delayed (Alugupalli, unpublished
data). These properties indicate that a subset of B1b cells behave like memory B cells. Reasons
that account for the evolution of the enhanced protection or antibody responses by such a subset
may include an expansion of antigen-specific B1b cells. In addition, antigenic stimulation may
have conferred upon the immune or convalescent mouse B1b cells a distinct property that naïve
B1b cells do not possess, similar to those that distinguish TD memory B cells from naïve B cells
as illustrated in Fig. 3.
The robust binding of B1b cell-derived IgM to B. hermsii without SHM (Alugupalli et
al., 2004) suggests an increased quantity of antigen-specific B1b cells in convalescent mice
rather than an affinity maturation of VH regions of specific B1b clones. Interestingly, the VH
sequences of the majority of the Ig repertoire of NP-Ficoll immunized mice have no SHM and
are of the IgM isotype (Maizels and Bothwell, 1985; Maizels et al., 1988). This unmutated IgM
response is not unique to the carrier, Ficoll. In fact, mice deficient in BCL6, which cannot
develop germinal center reaction, are capable of mounting hapten-specific antibody responses
when immunized with NP-conjugated to chicken gammaglobulins as a carrier, a frequently used
model TD antigen. The VH regions of the NP-specific IgM memory B cells in BCL6-/- mice are
also unmutated. These results indicate that generation of unmutated IgM memory occurs without
germinal center formation and is specific to the antigen driving such response (Toyama et al.,
2002). In fact, such an unmutated IgM response is sufficient for conferring immunity even to a
rapidly replicating bacterial pathogen, since TI control of B. hermsii occurs in AID-/- mice.
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Furthermore, we have also shown that convalescent AID-/- mice are also resistant to re-infection
demonstrating that the unmutated IgM memory of B1b cells is functional (Alugupalli et al.,
2004).
9
Concluding remarks
To date three distinct model systems have revealed that B1b cell subsets mount the majority of
the antigen-specific TI response (Alugupalli et al., 2003a; Alugupalli et al., 2004; Haas et al.,
2005; Hsu et al., 2006). This B1b cell subset is also capable of generating a unique response that
is functionally but not developmentally similar to the classical memory B cell response. The
generation of rapid and long-lasting IgM induction from the B1b cell subset, may not be an
unnecessary complexity in the seemingly linear conventional TD B cell memory development as
opinioned recently (Tarlinton, 2006). The existence of B1b cell memory does not appear to be a
redundant arm of the memory B cell compartment, as B1b cell memory has already been shown
to play an indispensable role in two clinically important bacterial infections (Alugupalli et al.,
2004; Haas et al., 2005). In fact, TD responses do not contribute to the protective immunity in
these systems. The dichotomy in the development of B cell memory, such as the generation of TI
memory B1b cells and canonical TD memory B cells seem to imply the humoral immune
system’s inherent strategy to cover two major categories of immunogens, the TI and TD
antigens, respectively. The division of labor by these two distinct arms of B cell memory could
ensure achieving “sterilizing” immunity to a wider range of pathogens in an overlapping and
timely fashion. The rapid and antigen-specific IgM response enhances the germinal center
reactions by forming antigen-IgM complexes and facilitates an accelerated development of high
affinity antibody response to TD antigens, suggesting a role for B1b-derived IgM in the
development of canonical B cell memory (Corley et al., 2005). In addition, B1b cell-derived TI
responses may also be beneficial in decreasing the incidence of morbidity associated with
opportunistic pathogens in individuals with decreased T cell counts and T-cell dysfunction
+

(Chinen and Shearer, 2002). For instance, a selective reduction in CD27 conventional memory
B cells in drug-naïve and in highly active anti-retroviral therapy-treated HIV-1-infected
individuals compromises their TD responses and increases susceptibility to a number of
opportunistic infections (Chong et al., 2004). Elucidation of the developmental pathways
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involved in B1b cell generation, activation, expansion and long-term maintenance of antigenspecific B1b cells may provide new approaches to the induction of long-lasting protective
antibody responses in individuals impaired in TI and/or TD responses.
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Figure legends

Figure 1.
A. Expansion of the B1b cell population in B. hermsii-infected mice. PerC cells of uninfected
or four-week post-infected xid (CBA/N) mice were harvested and stained with antibodies
specific for IgM, IgD and Mac1 or CD5 and analyzed by flow cytometry (Alugupalli et al.,
2003a). All B cells were first identified by IgD and IgM dual positivity (plots not shown) and
were further resolved as B1 (i.e. B1a + B1b) and B1a populations by Mac1 and CD5 positivity,
respectively. The percent frequency values of B1 and B1a cells, among the all PerC cells are
indicated within the plots. The frequency of B1b cells was inferred from values obtained from
+

+

the subtraction of the % of B1a (CD5 ) cells from the % of all B1 cells (Mac1 ). Data were
generated by analyzing a minimum of 20,000 cells and are representative of four separate
experiments. 5% contour plots are shown.
B. Persistent expansion of B1b lymphocytes in B. hermsii-infected mice. PerC cells of
uninfected or B. hermsii infected xid (CBA/N) mice at the indicated days post-infection (dpi)
were harvested and frequencies of B1b, B1a and B2 subsets were determined by flow cytometry.
high

low

+

-

high

low

+

The absolute cell counts of B1b (IgM , IgD , Mac1 and CD5 ), B1a (IgM , IgD , Mac1 and
+

high

low

-

CD5 ) and B2 (IgD , IgM , Mac1 ) were calculated as a product of their frequency and the
PerC cell yield. The mean ± SD values of respective subsets of three mice at the indicated dpi are
given. Significant expansion of B1b cells occurred in infected xid mice (**, p <0.002)
(Alugupalli et al., 2004).
C. Expansion of B1b cells is T cell-independent. PerC cells of naïve or convalescent (40 dpi)
-/-

TCR-βxδ mice were harvested and stained with IgM, IgD and Mac1 or CD5 and the absolute
cell numbers of B1b, B1a and B2 were determined. The mean ± SD values of five mice are
-/-

shown. Significant expansion of B1b cells occurred in infected TCR-βxδ mice (**, p <0.002)
(Alugupalli et al., 2004).
D. Rapid egress of B1b cells from the peritoneal cavity (PerC) during B. hermsii infection.
Wildtype mice were infected intravenously with 5 x 104 B.hermsii strain DAH-p1. On each of
the indicated days post-infection, three mice were sacrificed. Bacteremia and frequency of B1b
cells in the PerC were measured by microscopic counting and flow cytometry, respectively.
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Significant reduction of B1b cells occurred during the acute phase of the bacteremia (i.e. 2 and 3
dpi) (*, p <0.05)

Figure 2. Kinetics of the B. hermsii-specific IgM response in various knockout mice.
A. Wildtype (n=3), T cell-deficient (TCR-βxδ-/-; n=3), C3-/- (n=5) or IL=1R-/- (n=5) mice; B.
Wildtype (n=3) or mice deficient in either Btk (Btk KO; n=3) or MyD88 (MyD88 KO; n=3) or
both (Btk x MyD88 KO; n=4) were infected intravenously with 5 x 104 B.hermsii strain DAHp1. B. hermsii-specific IgM responses in the blood on the indicated days post-infection were
measured by ELISA and mean ± SD values are shown (Alugupalli et al., 2007).

Figure 3. A model for the efficient protection conferred by B1b cells to pathogens in
convalescent mice.
Upon infection or exposure to a specific T cell-independent antigen, B1b cells of varying
affinities generate a short-lived IgM response. In this primary response, a division of labor by
appropriate MZ B and/or B1a subsets (not shown in the figure) may also contribute to the IgM
response. While a significant fraction of this IgM may recognize the pathogens, only some of
this response is protective during primary infection. On the other hand, a subset of B1b cells
driven by specific antigens expand with the help of a T cell-independent co-stimulatory signal
(see Sect. 6), persist in convalescent mice with higher frequency, and maintain a quiescent state
in terms of their further differentiation into plasma cells. Such B1b cells acquire a functional
memory B1b cell phenotype. Compared to their naïve counterparts, the ability of memory B1b
cells to mount a heightened IgM response, upon antigen exposure, results in efficient protection
from re-infection. Factors that may contribute to this rapid response include an altered
transcriptomic profile and surface expression of other signaling receptors. Since AID can be
induced by BCR cross-linking and TLR stimulation, IgM secreting B1b cells could also switch
to other isotypes, such as IgG3.
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